IRVINE, Calif.--(BUSINESS WIRE)--Alsius Corporation (Nasdaq:ALUS), a worldwide leader in advanced patient temperature management therapies, today reported financial results for its second quarter ended June 30, 2007. Revenue for the quarter increased 108% to $2.5 million, compared with $1.2 million in the second quarter of 2006. Gross margin increased to $0.3 million, up from $(0.3) million in the second quarter of 2006. Net loss for the second quarter of 2007 increased 11% to $5 million or $0.42 per share, from $4.5 million or $0.41 per share for the second quarter of 2006. The company’s financial results are being reported for the first time since its listing on NASDAQ on July 12, 2007 as a result of its June 21 merger with Ithaka Acquisition Corporation.
